Nephrocheck after cardiac surgery: Does it play a role in daily practice? A sequel of “Nephrocheck results should be corrected for dilution”
- 31 May 2019
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 42 (11) , 665-667
Abstract
Acute kidney injury is a well-recognized complication after cardiac surgery and significantly affects morbidity and mortality. Although the mechanisms of acute kidney injury are not fully understood, Nephrocheck (Astute Medical, San Diego, CA, USA) is a meter for early detection of acute kidney injury based on bedside urinalysis of two cell-cycle arrest biomarkers. However, considerable overlap in the AKIRiskTM score of different RIFLE groups makes interpretation of the score uncertain. A possible reason for the overlap in the AKIRisk score between different RIFLE groups could be that the score is not corrected for dilution. We performed a pilot study to explore the applicability of the test in our daily practice. A total of 68 patients electively scheduled for cardiac surgery with at least two of the following inclusion criteria: age > 70 years, glomerular filtration rate <60 mL/min, left ventricular ejection fraction <41%, redo procedure and combined procedures have been enrolled in the study, and 25 of them developed acute kidney injury. We described the correlation between urine creatinine and Nephrocheck, all the samples with low Nephrocheck (<0.2) also have low urine creatinine, less than 50 mg/dL, detecting a potential diluted sample. In conclusion, in our daily practice AKIRisk score, together with an assessment of whether urine is diluted or concentrated can better discriminate between various degrees of acute kidney injury.Keywords
This publication has 8 references indexed in Scilit:
- NephroCheck: should we consider urine osmolality?Critical Care, 2019
- Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practiceClinical Chemistry and Laboratory Medicine (CCLM), 2018
- Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trialIntensive Care Medicine, 2017
- Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)Clinical Chemistry and Laboratory Medicine (CCLM), 2017
- Nephrocheck® results should be corrected for dilutionActa Anaesthesiologica Scandinavica, 2016
- Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk AssessmentAmerican Journal of Kidney Diseases, 2016
- The cell cycle biomarkers: promising research, but do not oversell themClinical Kidney Journal, 2016
- Urinary TIMP-2 and IGFBP7 as Early Biomarkers of Acute Kidney Injury and Renal Recovery following Cardiac SurgeryPLOS ONE, 2014